Health Trials

oGVHD

2

Review clinical trials related to oGVHD. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

2177GCCC:ID'Ing tx Targets and Biomarkers for Ocular Surface Disease in Pt w/ oGVHD

Evaluate and study the immunologic changes to the ocular surface in cancer patients.

Participants needed: 150
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: University of Maryland, BaltimoreUpdated: Feb 3, 2026Locations: 1
Eligibility criteria

Adult patients (≥ 18 years of age) who visit the Eye clinic either in the UMGCCC... [+1]

Vulnerable populations: neonates, children, prisoners, institutionalized individ... [+2]

Read more
Status: Available

Expanded Access for d-MAPPS™ Ophthalmic Solution, in the Treatment of Chronic Ocular Graft-Versus-Host Disease (oGVHD)

Regenerative Ocular Immunobiologics, LLC Fast Track Expanded Access This Expanded Access Policy describes the conditions under which ROI may make its investigational product - Sterile Processed Derived Multiple Allogeneic Proteins Paracrine Signaling (d-MAPPS™ Ophthalmic Solution) - available to patients outside of a clinical trial, in accordance with U.S. FDA regulations, including section 561A of the Federal Food, Drug, and Cosmetic Act (FDCA).

Trial details
Age: 18+Biological sex: AllType: Expanded AccessSponsor: Regenerative Ocular Immunobiologics LLCUpdated: Oct 10, 2025
Eligibility criteria

Age ≥18 years. [+8]

History of Rheumatoid Arthritis, Lupus, Scleroderma. (Exception may be made at t... [+14]

Read more